Cite
HARVARD Citation
Kedor, C. et al. (n.d.). THU0561 CANAKINUMAB FOR THE TREATMENT OF ADULT ONSET STILL'S DISEASE TO ACHIEVE REDUCTION OF ARTHRITIC MANIFESTATION AT WEEK 12: AN INVESTIGATOR-INITIATED MULTI-CENTRE, PLACEBO-CONTROLLED STUDY (CONSIDER). Annals of the rheumatic diseases. pp. 570-571. [Online].